Hepatocellular Carcinoma
Conditions
Interventions
phaseA:68Ga-NYM207
Queue 1:68Ga-NYM207
Queue 2:68Ga-NYM207
Sponsors
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 80 years; no gender restriction. 2. Must meet at least one of the following: (1) Patients with liver lesions planning to undergo surgical resection of the liver lesion within 1 month; (2) Clinically suspected recurrent/metastatic hepatocellular carcinoma; (3) Diagnosed with recurrent/metastatic hepatocellular carcinoma. 3. Before any evaluation, the subject or their legal representative understands and signs a written informed consent form, and the subject is willing and able to comply with all items of this study.
Exclusion criteria
Exclusion criteria: 1.Presence of cancer cachexxia, acute exacerbation of chronic disease, acute infection, immunodeficiency, or any other serious medical condition. 2.Diagnosis of claustrophobia. 3.History of substance abuse or alcoholism. 4.Pregnant or lactating women. 5.Poor venous access, unable to tolerate repeated venipuncture. 6.Receipt of investigational drugs or devices (with unclear efficacy or safety profiles) within the past month. 7.Any condition deemed by the principal investigator as posing actual or potential risk to the participant’s safety during any aspect of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dose;sensitivity ;specificity;Adverse Event (AE); | — |
Secondary
| Measure | Time frame |
|---|---|
| Imaging characteristics; | — |
Countries
China
Contacts
Public ContactLi Huo
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed